Heat to buy Pelican for preclinical cancer pipeline by Nick Paul Taylor Wednesday, March 8, 2017 Heat Biologics has struck a deal to buy a controlling stake in Pelican Therapeutics and its preclinical immuno-oncology R&D pipeline.
